Orange Grove Bio LLC

Orange Grove Bio LLC

Orange Grove Bio LLC operates as a life sciences- and therapeutics-focused investment firm, with reported office locations that span major US biotech hubs—Pasadena, Boston, Indianapolis, Chicago, Southfield—as well as Shanghai, China. The firm appears to allocate capital across early-stage biotechnology companies and therapeutic platforms, though no founding year, AUM, or named principals are disclosed in public records. The firm does not publicly disclose its investment vehicle structures, fund sizes, or portfolio companies. No recent operational events—such as fund closings, leadership changes, or notable investments—have been publicly reported in the last 24 months. The firm maintains a low public profile, and its professional headcount, team composition, and any associated philanthropic or adjacent vehicles are not identifiable from available sources. A key structural differentiator is the firm’s stated bi-coastal and international office network, which is uncommon for a firm of its apparent scale and may be designed to source cross-border life sciences opportunities. Without a confirmed leadership team or public track record, the firm’s actual deal capacity and expertise remain opaque.